Join the pharma and biotech R&D leaders, the top tech companies involved in clinical development and healthcare innovation, investigator sites, service companies, and the regulators from FDA and EMA at CNS Summit 2019. For three days, you’ll experience a dynamic environment for networking and idea-sharing, for learning from industry leaders and exploring the future [...]
For three days in November, you'll experience a dynamic environment for networking and idea sharing, for learning from industry leaders and exploring the future of drug development. You'll return to your office with a renewed perspective on industry trends and insight on what other leaders across the life sciences industry are doing for their organizations.
The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research. World CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees, helping to overcome the translational challenges in developing efficacious therapeutics. Developed in combination with experts from Biogen, Eisai, Merck, AbbVie and other leading organizations, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting.